Urological Devices – Market Insights – Latin America

The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of minimally invasive urological treatments. Furthermore, favorable demographic shifts, surging BPH and prostate cancer caseloads, declining ASPs enabling adoption in budget-constrained public systems, and enhanced physician training will fuel procedure volume growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for urological devices in Latin America from 2019 through 2034.

The Latin American urological device market is set to grow over the forecast period.

How will procedure trends affect market growth?

How are different segments expected to grow over the forecast period?

Post-sale services and product support are increasingly important to Latin American facilities when negotiating purchases of urological devices.

What other strategies are competitors using to set themselves apart in the Latin American market?

Economic constraints across the Latin American region have influenced purchasing decisions among healthcare facilities.

How will budgetary restrictions influence the urological device market?

How does rampant economic burden affect access to urological treatment?

Ongoing clinical studies and research continue to affect procedure trends, and thus device trends.

What do recent studies indicate regarding the outlook of existing techniques for treating prostate cancer, kidney stones, and BPH?

UI device segment accounts for a substantial share of total urological device market revenues.

What key factors drive UI device utilization?

How are ASPs for UI devices expected to evolve through 2034?